Comparative Analysis of Efficacy and Safety Between Benvitimod and Halometasone in Individuals with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Open-Label Randomized Trial - Poll - MDSpire

Comparative Analysis of Efficacy and Safety Between Benvitimod and Halometasone in Individuals with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Open-Label Randomized Trial

  • By

  • Yuan Chang

  • Gongfeng Tang

  • Haixuan Wu

  • Xuelei Liang

  • Yi Liu

  • Fenglin Zhuo

  • February 13, 2026

  • 0 min

Share

Original Source(s)

Comparative Analysis of Efficacy and Safety Between Benvitimod and Halometasone in Individuals with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Open-Label Randomized Trial

  • by Yuan Chang, Gongfeng Tang, Haixuan Wu, Xuelei Liang, Yi Liu, Fenglin Zhuo

  • February 13, 2026

Related Content

Connecting the Diagnostic Dots in HIES

Clinical case report highlights how classic features of STAT3 hyper-IgE syndrome can be routinely missed in pediatric practice

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

IL-17, IL-23 Therapies Lead Psoriasis Care

Network meta-analysis suggests higher PASI 90 response rates with biologics vs oral systemic therapies